Targeted Therapy for Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Featuring perspectives from Drs Zofia Piotrowska and Gregory Riely, including the following topics: Introduction: What Is Targeted Therapy? (0:00) EGFR-Activating Mutations (12:23) EGFR Exon 20 Insertion Mutations (27:54) ALK and ROS1 Rearrangements (31:31) HER2 Mutations (36:17) NRG1 Fusions (45:39) RET Fusions (49:07) MET Exon 14 Mutations (53:10) KRAS G12C Mutations (56:01) CME information and select publications